Literature DB >> 22266235

High-frequency ultrasound for in vivo measurement of colon wall thickness in mice.

Mostafa A Abdelrahman1, Gemma Marston, Mark A Hull, Alexander F Markham, Pamela F Jones, J Anthony Evans, P Louise Coletta.   

Abstract

Mouse models are becoming increasingly important in the study of molecular mechanisms of colorectal disease and in the development of novel therapeutics. To enhance this phase of preclinical research, cost-effective, easy to use noninvasive imaging is required to detect and monitor changes in the colon wall associated with disease pathology. This study investigated the feasibility of using 40-MHz (high frequency) B-mode ultrasound (HF-US) to image the normal mouse colon and measure its thickness in vivo by establishing a robust imaging protocol and conducting a blinded comparison of colon wall thickness (CWT) measurement between and within operators. The in vivo and ex vivo appearance of mouse colon under HF-US revealed distinct patterns. Colon wall thickness was reproducibly and accurately measured using HF-US compared with histology measurement. The technique was more sensitive in detecting changes in CWT in distal than proximal colon as it showed the highest level of inter- and intraoperator reproducibility. Using the protocol described, it is possible to detect changes in thickness of 0.09 mm and 0.25 mm in distal and proximal colon, respectively. In conclusion, HF-US provides an easy to use and noninvasive method to perform anatomical investigations of mouse colon and to monitor changes in CWT.
Copyright © 2012 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22266235     DOI: 10.1016/j.ultrasmedbio.2011.12.011

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

Review 1.  Non-invasive molecular imaging for preclinical cancer therapeutic development.

Authors:  A C O'Farrell; S D Shnyder; G Marston; P L Coletta; J H Gill
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

2.  Development of orthotopic tumour models using ultrasound-guided intrahepatic injection.

Authors:  L E McVeigh; I Wijetunga; N Ingram; G Marston; R Prasad; A F Markham; P L Coletta
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

3.  Assessment of Murine Colon Inflammation Using Intraluminal Fluorescence Lifetime Imaging.

Authors:  Alba Alfonso-Garcia; Stephanie A Cevallos; Jee-Yon Lee; Cai Li; Julien Bec; Andreas J Bäumler; Laura Marcu
Journal:  Molecules       Date:  2022-02-15       Impact factor: 4.411

4.  The use of high-frequency ultrasound imaging and biofluorescence for in vivo evaluation of gene therapy vectors.

Authors:  Nicola Ingram; Stuart A Macnab; Gemma Marston; Nigel Scott; Ian M Carr; Alexander F Markham; Adrian Whitehouse; P Louise Coletta
Journal:  BMC Med Imaging       Date:  2013-11-12       Impact factor: 1.930

5.  Mapping O2 concentration in ex-vivo tissue samples on a fast PLIM macro-imager.

Authors:  Rajannya Sen; Alexander V Zhdanov; Thomaz F S Bastiaanssen; Liisa M Hirvonen; Peter Svihra; Patrick Fitzgerald; John F Cryan; Stefan Andersson-Engels; Andrei Nomerotski; Dmitri B Papkovsky
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

6.  Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues.

Authors:  Nicola Ingram; Laura E McVeigh; Radwa H Abou-Saleh; Juliana Maynard; Sally A Peyman; James R McLaughlan; Michael Fairclough; Gemma Marston; Elizabeth M A Valleley; Jorge L Jimenez-Macias; Antonia Charalambous; William Townley; Malcolm Haddrick; Antonia Wierzbicki; Alexander Wright; Milène Volpato; Peter B Simpson; Darren E Treanor; Neil H Thomson; Paul M Loadman; Richard J Bushby; Benjamin R G Johnson; Pamela F Jones; J Anthony Evans; Steven Freear; Alexander F Markham; Stephen D Evans; P Louise Coletta
Journal:  Theranostics       Date:  2020-09-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.